Harrow Health (HROW) Stock Research

Today

Harrow reports Q2 EPS (46c), consensus (24c)

HROW

5:06 PM

Thursday

Harrow to acquire global rights to Tyrvaya from Viatris for up to $100M

Aug 6, 9:04 AM

Over a week ago

Harrow and Samsung Bioepis present interim BYOOVIZ post-marketing data

HROW

Jul 20, 9:23 AM

Harrow announces commercial launch of Byooviz in the U.S.

HROW

Jul 1, 7:19 AM

Harrow announces commercial launch of BYOOVIZ in U.S.

HROW

Jul 1, 7:07 AM

Harrow CEO buys $302K, CFO buys $104.7K in common stock

HROW

May 15, 9:48 AM

Harrow price target lowered by $5 at B. Riley, here's why

HROW

May 14, 9:25 AM

Harrow price target lowered by $3 at Cantor Fitzgerald

HROW

May 13, 8:43 AM

Closing Bell Movers: Hims & Hers down 12% on earnings miss

+14

May 11, 7:21 PM

Harrow reports Q1 EPS (74c) vs. (50c) last year

HROW

May 11, 4:21 PM

Harrow announces issuance of J-Code for Iopidine 1%

HROW

Apr 16, 7:24 AM

Harrow selects LogiCare3PL as distribution partner

HROW

Apr 14, 10:33 AM

Harrow management to meet virtually with BTIG

HROW

Apr 9, 4:25 PM

Harrow management to meet virtually with BTIG

HROW

Apr 9, 4:24 PM

Harrow price target lowered by $9 at B. Riley, here's why

HROW

Apr 7, 7:59 AM

Harrow management to meet with Craig-Hallum

HROW

Mar 5, 4:55 AM

Harrow price target lowered by $10 at Lake Street, here's why

HROW

Mar 4, 8:43 AM

Harrow price target lowered by $3 at Cantor Fitzgerald, here's why

HROW

Mar 4, 8:18 AM

Harrow price target lowered by $4 at Ladenburg, here's why

HROW

Mar 4, 7:38 AM

Harrow price target raised by $1 at H.C. Wainwright, here's why

HROW

Mar 4, 6:06 AM

Harrow announces U.S. FDA cleared an IND application for trial of Triesence

HROW

Mar 3, 7:13 AM

Closing Bell Movers: MongoDB down over 20% after soft Q1 guidance

+17

Mar 2, 7:34 PM

Harrow sees FY26 revenue $350M-$365M, consensus $386.39M

HROW

Mar 2, 4:27 PM

Today

Harrow reports Q2 EPS (46c), consensus (24c)

HROW

5:06 PM

Thursday

Harrow to acquire global rights to Tyrvaya from Viatris for up to $100M

Aug 6, 9:04 AM

Over a week ago

Harrow and Samsung Bioepis present interim BYOOVIZ post-marketing data

HROW

Jul 20, 9:23 AM

Harrow announces commercial launch of Byooviz in the U.S.

HROW

Jul 1, 7:19 AM

Harrow announces commercial launch of BYOOVIZ in U.S.

HROW

Jul 1, 7:07 AM

Harrow CEO buys $302K, CFO buys $104.7K in common stock

HROW

May 15, 9:48 AM

Harrow price target lowered by $5 at B. Riley, here's why

HROW

May 14, 9:25 AM

Harrow price target lowered by $3 at Cantor Fitzgerald

HROW

May 13, 8:43 AM

Closing Bell Movers: Hims & Hers down 12% on earnings miss

+14

May 11, 7:21 PM

Harrow reports Q1 EPS (74c) vs. (50c) last year

HROW

May 11, 4:21 PM

Harrow announces issuance of J-Code for Iopidine 1%

HROW

Apr 16, 7:24 AM

Harrow selects LogiCare3PL as distribution partner

HROW

Apr 14, 10:33 AM

Harrow management to meet virtually with BTIG

HROW

Apr 9, 4:25 PM

Harrow management to meet virtually with BTIG

HROW

Apr 9, 4:24 PM

Harrow price target lowered by $9 at B. Riley, here's why

HROW

Apr 7, 7:59 AM

Harrow management to meet with Craig-Hallum

HROW

Mar 5, 4:55 AM

Harrow price target lowered by $10 at Lake Street, here's why

HROW

Mar 4, 8:43 AM

Harrow price target lowered by $3 at Cantor Fitzgerald, here's why

HROW

Mar 4, 8:18 AM

Harrow price target lowered by $4 at Ladenburg, here's why

HROW

Mar 4, 7:38 AM

Harrow price target raised by $1 at H.C. Wainwright, here's why

HROW

Mar 4, 6:06 AM

Harrow announces U.S. FDA cleared an IND application for trial of Triesence

HROW

Mar 3, 7:13 AM

Closing Bell Movers: MongoDB down over 20% after soft Q1 guidance

+17

Mar 2, 7:34 PM

Harrow sees FY26 revenue $350M-$365M, consensus $386.39M

HROW

Mar 2, 4:27 PM

Company News

Charts